PATENT CLAIM ANALYSIS

Application Number: 16034775
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["536", "024100"]

Abstract:
The present invention pertains to novel oligonucleotide compounds for use in various biological assays, such as nucleic acid amplification, ligation and sequencing reactions. The novel oligonucleotides comprise a ribonucleic acid domain and a blocking group at or near the 3′ end of the oligonucleotide. These compounds offer an added level of specificity previously unseen. Methods for performing nucleic acid amplification, ligation and sequencing are also provided. Additionally, kits containing the oligonucleotides are also disclosed herein.

Claim (Index 8):
The kit of  claim 1 , wherein the ligation agent is a DNA ligase enzyme.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.47368
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12507142', '13429077', '14123944', '13959637', '15101551']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7426125714615455
- 35 USC 102 Novelty (BERT): 0.5745227001277178
- Combined Prediction Score: 0.7258035843281627
- Mean Citation Score: 511.188666
- Max Citation Score: 568.563
- Similarity Product: 374.274541277647

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test